Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aditya Bansal

Thoracic Surgery (Cardiothoracic Vascular Surgery) New Orleans, LA Medical Doctor

NPI 1922219815 CMS profile 1044608

1514 Jefferson Hwy, New Orleans, LA 70121

Open in the dashboard

General payments

$139,832

238 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$528,332 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Aditya Bansal of New Orleans, LA is reported in the CMS Open Payments database as having received $139,832 across 238 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $528,332 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $419 6
2024 General $1,030 19
2023 General $3,980 21
2022 General $31,684 55
2021 General $14,864 26
2020 General $14,665 18
2019 General $73,189 93

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aditya Bansal
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Aditya Bansal were reported at $419. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Aditya Bansal Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $73,189 $886 $178–$3,167 $163
2020 $14,665 $341 $108–$1,605 $114
2021 $14,864 $453 $125–$1,886 $132
2022 $31,684 $695 $180–$2,566 $149
2023 $3,980 $745 $205–$2,662 $160
2024 $1,030 $799 $214–$2,967 $164
2025 $419 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $105,698 171 payments
  2. LivaNova USA, Inc. $26,981 17 payments
  3. Abiomed $6,012 32 payments
  4. Medtronic, Inc. $605 10 payments
  5. CVRx, Inc. $348 3 payments
  6. Medtronic Vascular, Inc. $148 3 payments
  7. Corcym Inc $39 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $73,690 55 payments
  2. Travel and Lodging $27,055 48 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,255 8 payments
  4. Food and Beverage $6,207 121 payments
  5. Honoraria $3,000 1 payment
  6. Compensation for serving as faculty or as a speaker for a medical education program $2,125 3 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,500 2 payments
Products named General payments · program years 2019–2025
  1. HeartMate 3 Left Ventricular Dev $46,323 43 payments
  2. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $32,749 69 payments
  3. TandemLife $26,746 15 payments
  4. CentriMag $8,211 10 payments
  5. CardioMEMS HF System Cardiac Arrhythmias and Heart Failure $7,500 5 payments
  6. Impella $5,946 30 payments
  7. HeartMate 3 Left Ventricular Assist Device $3,653 13 payments
  8. CARDIOMEMS $2,125 3 payments
  9. CardioMEMS HF System Heart failure $2,000 2 payments
  10. HeartMate Touch $1,000 1 payment
  11. Other $3,504 44 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 21 billing codes

Paid by Medicare

$20,794

Medicare's payments for the services billed

Medicare patients

56

Average age 69

Services billed

71

18 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 70%
Ischemic heart disease 70%
Chronic kidney disease 50%
Diabetes 46%
Arthritis 39%
Atrial fibrillation 29%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

238 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record